Tender Title: DGLP SKIN 01
Reference Number: ae896f6a
Issuing Authority/Department: Department of Military Affairs, Ministry of Defence
The DGLP SKIN 01 tender invites bids for the procurement of specialized pharmaceutical products, specifically a formulation comprising 0.05 percent Halobetasol Propionate plus 3 percent Salicylic acid lotion and Acyclovir Skin Ointment, with a total quantity requirement of 2410 units. This tender is part of a comprehensive effort to supply the necessary dermatological treatments within military healthcare facilities.
Scope of Work and Objectives
The primary objective of this tender is to ensure the provision of high-quality dermatological products that meet the standards set forth in the medical and pharmaceutical fields. The suppliers will be responsible for the manufacture, quality assurance, and timely delivery of the specified items, ensuring compliance with all relevant health regulations and standards.
Eligibility Criteria
Interested bidders must meet the following eligibility criteria:
- Registration as a pharmaceutical manufacturer or supplier.
- Valid licenses and certifications necessary for the production and distribution of pharmaceutical products.
- Proven experience in supplying similar products to government or military entities.
Technical Requirements
The bidders must ensure that the products supplied:
- Meet the specified formulation details of 0.05 percent Halobetasol Propionate plus 3 percent Salicylic acid lotion and Acyclovir Skin Ointment.
- Comply with all applicable guidelines and standards for pharmaceutical products, including efficacy and safety protocols.
- Provide documentation validating quality control measures and testing processes utilized in the manufacturing of the products.
Financial Requirements
Bidders must demonstrate financial stability and the ability to supply the needed quantities without delay. Financial statements may be required for verification. Additionally, an Earnest Money Deposit (EMD) is to be submitted as part of the bidding process to secure the bid.
Document Submission Details
Bidders must submit their proposals electronically through the prescribed government procurement portal. All required documentation, including technical and financial bids, must be uploaded in specified formats, ensuring clarity and compliance with submission guidelines.
Special Provisions
The tender encourages participation from Micro, Small, and Medium Enterprises (MSEs) and startups. These entities may benefit from relaxed eligibility norms, aimed at boosting local participation and fostering innovation within the sector.
Evaluation Process
The evaluation of bids will be conducted systematically, focusing on the technical merits of the proposals, including compliance with the technical specifications, the financial proposals reflecting competitive pricing, and overall responsiveness to the tender requirements. The government's procurement guidelines will be strictly adhered to during this process to ensure transparency and fairness.
Delivery Locations
Successful bidders will be responsible for delivering the products to designated military healthcare facilities as outlined in the tender documentation, ensuring adherence to delivery timelines and quality standards.
Contact Information
For any queries related to this tender, interested parties may contact the Department of Military Affairs through the official channels. Please ensure questions are directed to the appropriate department to facilitate prompt responses.
Conclusion
The DGLP SKIN 01 tender represents an important initiative by the Ministry of Defence to enhance healthcare provisions for military personnel. It presents a significant opportunity for qualified pharmaceutical manufacturers and suppliers to contribute to this vital area.
Tender BOQ Items
14 ItemsGeneral Information
Financial Information
Evaluation and Technical Information
Tender Documents
4 DocumentsSimilar Tenders
Frequently Asked Questions
The eligibility requirements include being a registered entity in the relevant pharmaceutical sector, possessing valid licenses for manufacturing and distribution, and demonstrating experience in supplying similar products to government or military clients. Entities must ensure compliance with all local laws and industry regulations to be considered.
Bidders must ensure that the products conform to the stated formulation of 0.05 percent Halobetasol Propionate plus 3 percent Salicylic acid lotion and Acyclovir Skin Ointment. Additionally, products must comply with stringent medical and pharmaceutical standards regarding efficacy, safety, and quality control measures.
The Earnest Money Deposit (EMD) serves as a security measure during the bidding process. Interested bidders must submit the EMD, the amount and conditions of which are specified in the tender documentation. It ensures commitment from bidders and will be refunded post-evaluation to non-successful bidders.
Proposals must be submitted electronically through the designated government procurement portal. All submissions should include both technical and financial documents in the accepted formats, ensuring proper organization for evaluation. Failure to comply with submission guidelines may lead to disqualification.
Yes, this tender encourages participation from Micro, Small, and Medium Enterprises (MSEs). There are relaxed eligibility norms and potential incentives aimed at promoting local contributions to the tender, helping to foster innovation and enhance competition within the pharmaceutical supply chain.
Probable Bidders
Get Tender Alerts
Get notifications for similar tenders